$LONN #Lonza Group AG Intron Health - Lonza: Upside Aplenty – PT up to CHF580: Our LBPN deep-dive leads us to believe there is considerable upside from new modalities, US &amp; EU onshoring trends, the IBEX platform &amp; the newly signed Moderna… https://t.co/jsh9ZT8ly9 #equity #stocks https://t.co/0WONDtpg0N